# vaccination

## Project Description

Many countries, especially low and middle income countries, are facing limited vaccination supply and fearing the increasingly wide-spread emergence of faster-spreading SARS-CoV-2 virus variants.

The majority of available vaccines require two immunization shots to provide maximum protection. Yet, the immunological response to the first (''prime'') injection may already  provide a substantial degree of protection against infection. Thus, it may be more effective to vaccinate as many people as possible with only one shot, instead of administering a person a second (''boost'') shot. Such a strategic vaccination campaign may help to more effectively slow down the spread of SARS-CoV-2, thereby reducing fatalities and the risk of collapsing health care systems.

To help explore the conditions which make single-dose vaccination favourable over prime-boost administrations, we combine epidemiological modeling, random sampling techniques, and decision tree learning.

A schematic of prime-first and prime-boost vaccination campaigns and our SEIR model extension is shown below. Panels (a,b) show the evolution of the number of prime and prime-boost vaccianted individuals. Model compartments and transitions are shown in panel (c).

![Image](illustration_final.png)

## Reference
* L. BÃ¶ttcher, J. Nagler, [Decisive Conditions for Strategic Vaccination against SARS-CoV-2](https://www.medrxiv.org/content/10.1101/2021.01.10.21249524v1.full)

```
@article{bottcher2021decisive,
  title={Decisive Conditions for Strategic Vaccination against SARS-CoV-2},
  author={B{\"o}ttcher, Lucas and Nagler, Jan},
  journal={medrxiv preprint medrxiv:},
  year={2021}
}
```
